Utilization of a MAB for BRAFV600E detection in papillary thyroid carcinoma

Immunohistochemical Detection of the BRAF V600E-mutated Protein in Papillary Thyroid Carcinoma

(2012) Oskar Koperek et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

A High Percentage ofBRAFV600EAlleles in Papillary Thyroid Carcinoma Predicts a Poorer Outcome

(2012) Anna Guerra et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibody

(2011) David Capper et al.   ACTA NEUROPATHOLOGICA

The Primary Occurrence ofBRAFV600EIs a Rare Clonal Event in Papillary Thyroid Carcinoma

(2011) Anna Guerra et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Molecular genetics and diagnosis of thyroid cancer

(2011) Yuri E. Nikiforov et al.   Nature Reviews Endocrinology

Correlation between theBRAFV600E Mutation and Tumor Invasiveness in Papillary Thyroid Carcinomas Smaller than 20 Millimeters: Analysis of 1060 Cases

(2010) Fulvio Basolo et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

BRAFV600E mutation is associated with an increased risk of nodal recurrence requiring reoperative surgery in patients with papillary thyroid cancer

(2010) Christine J. O’Neill et al.   SURGERY